Glutathione and growth inhibition of Mycobacterium tuberculosis in healthy and HIV infected subjects
2006

Glutathione and its role in fighting tuberculosis in healthy and HIV-infected individuals

Sample size: 20 publication Evidence: moderate

Author Information

Author(s): Venketaraman Vishwanath, Rodgers Tatanisha, Linares Rafael, Reilly Nancy, Swaminathan Shobha, Hom David, Millman Ariel C, Wallis Robert, Connell Nancy D

Primary Institution: UMDNJ-New Jersey Medical School

Hypothesis

The study examines the role of glutathione in immunity against tuberculosis infection in healthy and HIV-infected subjects.

Conclusion

The study found that treatment with N-acetyl cysteine improved the immune response to control Mycobacterium tuberculosis infection in HIV-infected subjects.

Supporting Evidence

  • Glutathione levels were significantly lower in HIV-infected subjects compared to healthy controls.
  • N-acetyl cysteine treatment improved the immune response in HIV-infected subjects.
  • Pro-inflammatory cytokines were down-regulated in NAC-treated cultures.

Takeaway

This study shows that a substance called glutathione helps our body fight off a germ that causes tuberculosis, especially in people with HIV.

Methodology

The study involved 20 subjects, including 10 healthy controls and 10 HIV-infected patients, who were tested for glutathione levels and their ability to control M. tuberculosis infection.

Limitations

The study only included a small sample size and did not account for all variables affecting tuberculosis infection.

Participant Demographics

10 healthy volunteers and 10 HIV-infected patients, with an average CD4 count of 423 ± 83/cumm.

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1742-6405-3-5

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication